Business Standard

Volume Shocker: Mastek

A combined 386,658 shares have changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks

Related News

Mastek has surged 14% to Rs 105 on back of over fifteen-fold jump in trading volumes in noon deals on the National Stock Exchange. As many as a combined 386,658 shares have already changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks on both the exchanges.

had reported first quarterly profit of Rs 7.1 crore after six quarters for the quarter ended March 2012 and management commentary suggests likely continuation of this trend.

The operational performance was healthy across major geographies and verticals with the company generating around Rs 32 crore from cash flow from operations.

Analyst at ICICI Direct Research upgraded the stock to BUY with a target price of Rs 120, on positive outlook by the management may minimise the risk of book value erosion. 

Read more on:   
|
|

Volume Shocker: Mastek

A combined 386,658 shares have changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks

Mastek has surged 14% to Rs 105 on back of over fifteen-fold jump in trading volumes in noon deals on the National Stock Exchange. As many as a combined 386,658 shares have already changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks on both the exchanges.

Mastek has surged 14% to Rs 105 on back of over fifteen-fold jump in trading volumes in noon deals on the National Stock Exchange. As many as a combined 386,658 shares have already changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks on both the exchanges.

had reported first quarterly profit of Rs 7.1 crore after six quarters for the quarter ended March 2012 and management commentary suggests likely continuation of this trend.

The operational performance was healthy across major geographies and verticals with the company generating around Rs 32 crore from cash flow from operations.

Analyst at ICICI Direct Research upgraded the stock to BUY with a target price of Rs 120, on positive outlook by the management may minimise the risk of book value erosion. 

image

Read More

Sensex zooms 439 pts on GAAR relief, EU deal

The stock markets surged over two per cent on Friday on heavy buying from foreign investors after the government soothed their nerves by proposing ...

Recommended for you

Quick Links

Market News

Nickel rises by 0.1% on Asian cues

Traders strengthened positions amid a firming Asian cues

Oil prices rise further in Asia

Expectations of a decline in US crude inventories and robust economic data from the eurozone helped prices

Markets remain rangebound; HUL up over 2%, Hindalco dips 1%

Investors are optimistic about a possible solution between Greece and its international creditors to avert a debt crisis

Pharma shares in focus; Aurobindo Pharma hits new high

JB Chemicals, Alembic Pharma, Aurobindo Pharma, Ipca Laboratories and Dishman Pharma were up 3%-11% each.

Infinite Computer gains on board approval for share buyback proposal

The stock spurted 5% at Rs 171 after the board approved the buyback of shares at a maximum price of Rs 220 per share from the open market ...

 

Back to Top